Literature DB >> 12755369

Host defences to Citrobacter rodentium.

Thomas T MacDonald1, Gad Frankel, Gordon Dougan, Nathalie S Goncalves, Cameron Simmons.   

Abstract

Citrobacter rodentium is a natural non-invasive bacterial pathogen which infects the distal colon of mice. It uses the same molecular mechanisms of type III secretion as human enteropathogenic and enterohemorrhagic Escherichia coli to colonise the epithelial cells of the gut and is therefore an ideal model to study host-bacterial pathogen interactions in vivo. Infection elicits mucosal inflammation with similarities to inflammatory bowel disease, and so it is a readily accessible model to investigate the relationship between inflammation and anti-bacterial immunity in the gut.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12755369     DOI: 10.1078/1438-4221-00247

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  21 in total

1.  Polyethylene glycol diminishes pathological effects of Citrobacter rodentium infection by blocking bacterial attachment to the colonic epithelia.

Authors:  Wentao Qi; Suhasini Joshi; Christopher R Weber; Ramesh K Wali; Hemant K Roy; Suzana D Savkovic
Journal:  Gut Microbes       Date:  2011-09-01

2.  Effect of probiotics Lactobacillus acidophilus on Citrobacter rodentium colitis: the role of dendritic cells.

Authors:  Chien-Chang Chen; Cheng-Hsun Chiu; Tzou-Yien Lin; Hai Ning Shi; W Allan Walker
Journal:  Pediatr Res       Date:  2009-02       Impact factor: 3.756

3.  CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium.

Authors:  Lynn Bry; Manfred Brigl; Michael B Brenner
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Role of class 1 serine protease autotransporter in the pathogenesis of Citrobacter rodentium colitis.

Authors:  Vidhya Vijayakumar; Araceli Santiago; Rachel Smith; Mark Smith; Roy M Robins-Browne; James P Nataro; Fernando Ruiz-Perez
Journal:  Infect Immun       Date:  2014-04-07       Impact factor: 3.441

5.  Lymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection.

Authors:  Yugang Wang; Ekaterina P Koroleva; Andrei A Kruglov; Dmitry V Kuprash; Sergei A Nedospasov; Yang-Xin Fu; Alexei V Tumanov
Journal:  Immunity       Date:  2010-03-11       Impact factor: 31.745

6.  The pathogenicity of an enteric Citrobacter rodentium Infection is enhanced by deficiencies in the antioxidants selenium and vitamin E.

Authors:  Allen D Smith; Sebastian Botero; Terez Shea-Donohue; Joseph F Urban
Journal:  Infect Immun       Date:  2011-01-18       Impact factor: 3.441

Review 7.  In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections.

Authors:  Robyn J Law; Lihi Gur-Arie; Ilan Rosenshine; B Brett Finlay
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

8.  Activation of p38α in T cells regulates the intestinal host defense against attaching and effacing bacterial infections.

Authors:  Eun-Jin Shim; Bo Ram Bang; Seung-Goo Kang; Young Jun Kang; Jianhui Ma; Motoyuki Otsuka; Jiman Kang; Martin Stahl; Jiahuai Han; Changchun Xiao; Bruce A Vallance
Journal:  J Immunol       Date:  2013-08-05       Impact factor: 5.422

9.  The Citrobacter rodentium mouse model: studying pathogen and host contributions to infectious colitis.

Authors:  Ganive Bhinder; Ho Pan Sham; Justin M Chan; Vijay Morampudi; Kevan Jacobson; Bruce A Vallance
Journal:  J Vis Exp       Date:  2013-02-19       Impact factor: 1.355

10.  Mucin dynamics in intestinal bacterial infection.

Authors:  Sara K Lindén; Timothy H J Florin; Michael A McGuckin
Journal:  PLoS One       Date:  2008-12-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.